NEW YORK (TheStreet) -- Shares of Aetna (AET) finished the day higher by 3.09% to $101.84 on Friday afternoon, as the health insurance company prepares to report its fiscal 2015 fourth quarter earnings results before the market open on Monday.
Analysts are expecting Aetna to post a slight decline in its earnings per share year over year. Revenue, however, is expected to rise slightly for the most recent quarter.
Thomson Reuters analysts have forecast for earnings of $1.21 per share on revenue of $14.93 billion for the three month period ended December 2015.
Aetna's earnings came in at $1.22 per share on revenue of $14.77 billion for the 2014 fourth quarter.
Over the summer, Aetna agreed to buy fellow insurance company Humana (HUM) in a $34.1 billion cash and stock deal. The transaction is said to be on track to close this year, according to Reuters.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:
We rate AETNA INC as a Buy with a ratings score of B+. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel its strengths outweigh the fact that the company has had sub par growth in net income.
You can view the full analysis from the report here: AET